Skip to main content
Quest Diagnostics

Hepatitis C: Implementing the New Guidelines During the Pandemic

Description: Dr. William J. Becker along with Dr. Weston Rothrock, discuss the best ways to navigate patient return to care during COVID-19, USPSTF guidelines for universal Hepatitis C screening and identify groups at higher risk for HCV.

 

At the conclusion of this program, participants will be able to:

  -  Discuss the best ways to navigate patient return to care during COVID-19.

  -  Explain the importance of following USPSTF guidelines for universal

     Hepatitis C screening.

  -  Identify cross-generational groups considered to be at higher risk for HCV.

 

 

Date:
Sep 01, 2020
Presenter(s):

 

  -  William J Becker, DO, MPH, Clinical Pathology Medical

     Director Quest Diagnostics, Lenexa, Kansas 

 

  -  Weston H. Rothrock, MD, Associate Medical Director,

     Tampa, Florida,

      Laboratory Medical Director, Rapid Response

      Laboratories,  Jacksonville, Leesburg, Largo, Florida 

Related content

Conference Presentation
HCV Testing Overview
Publication
Hepatitis C virus clearance cascade — United States, 2013–2022
Publication
Decreases in Hepatitis C Testing and Treatment During the COVID 19 Pandemic
Publication
Hepatitis C Virus Testing During Pregnancy Following Universal Screening Recommendations
Publication
Testing for Hepatitis C During Pregnancy Among Persons With Medicaid and Commercial Insurance: Cohort Study
Test FAQ
Donor Testing
On-Demand Webinar
HBV Webinar: From Screening to Functional Cure

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.